Evidence map›Paper›PMID 27664376›Full record

ArticleNeoplasia (New York, N.Y.)2016

p53 and p16

Stephanie Azzopardi, Sharon Pang, David S Klimstra, Yi-Chieh Nancy Du

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neoplasia (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Stephanie AzzopardiDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Sharon PangDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
David S KlimstraDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Yi-Chieh Nancy DuDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: nad2012@med.cornell.edu.
Cornell University · USMemorial Sloan Kettering Cancer Center · USWeill Cornell Medicine · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Coordinating Center for Beta Cell Biology ConsortiumU01DK072473 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2005 to 2014
$61.0M
Autophagy in Pancreatic Neuroendocrine Tumor Growth and MetastasisR21CA173348 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DU, YI-CHIEH NANCY, JIANG, XUEJUN · 2013 to 2014
$425k
NCI NIH HHS P30 CA008748NCI NIH HHS R21 CA173348NIDDK NIH HHS U01 DK072473
6 · The paper itself

Abstract

In human studies and mouse models, the contributions of p53 and p16

Indexed as

AnimalsCell Transformation, NeoplasticCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p19Disease Models, AnimalFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMiceMice, TransgenicNeoplasm MetastasisNeoplastic Stem CellsNeuroendocrine TumorsPancreatic NeoplasmsCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p19Tumor Suppressor Protein p53

Identifiers

PMID27664376
PMCPMC5035259
OpenAlexW2521803386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.